Andrey Leonidovich Zaplatnikov

Andrey Leonidovich Zaplatnikov

Auto-generated profile, based on publicly available information

Andrey Leonidovich Zaplatnikov

Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Problems of Virology
Verified
Journal Article
Open access
PDF file
DLD. K. L’vOv
D. K. L’vOv
EBElena Ivanovna Burtseva
Elena Ivanovna Burtseva
LKL. V. Kolobukhina
L. V. Kolobukhina
IFI. T. Fedyakina
I. T. Fedyakina
Nicolai BovinNicolai Bovin
Nicolai Bovin
ASA. V. Shikhin
A. V. Shikhin
Introduction. The surveillance of influenza viruses in ARVI structure and study of their properties in epidemic season 2019–2020 in Russian Federation are actual for investigations due to tasks of Global Influenza Strategy initiated by WHO in 2019.Material and methods. The data of epidemiological surveillance on influenza- and ARVI-associated morbidity and hospitalization in different age groups of population were analyzed; virological, genetic and statistical methods were used.Results. Preschool children were involved in epidemic the most. Meanwhile, the highest rate of hospitalization was observed in patients of 18–40 years old. Influenza A(H1N1)pdm09 virus dominated in etiology of ARVI in hospitalized patients and pneumonia. The role of respiratory viruses in severe cases of pneumonia and bronchoalveolar syndrome in children was shown. The differences in spectrum of circulating viruses caused ARVI in different regions of Russia were found. Influenza A(H1N1)pdm09 and B/Victoria-like viruses were the main etiological agents that caused of epidemic; its activity among all ARVI was 7.3 and 8.0%, respectively. The differences in antigenic properties of influenza A(H3N2) and B epidemic strains compared to vaccine viruses were found. The populations of epidemic strains were presented by following dominant genetic groups: 6B1.A5/183P for A(H1N1)pdm09, 3С.2а1b+137F for A(H3N2) and V1A.3 line B/Victoria-like for B viruses. The good profile of epidemic strains susceptibility to anti-neuraminidase inhibitors has been saved. The most of the studied influenza strains had the receptor specificity characteristic of human influenza viruses.Conclusions. Obtained results identified the peculiarities of viruses caused the influenza and ARVI in epidemic season 2019–2020 in different regions of Russia. These results suggested the important role of influenza A(H1N1) pdm09 in severe cases and pneumonia in adults 18–40 years old. The continuing drift in influenza viruses was found, which, apparently, could not but affect the efficacy of vaccine prophylaxis and was also considered in the recommendations of WHO experts on the composition of influenza vaccines for the countries of the Northern Hemisphere in the 2020–2021 season.

1 January 2020 in Russian Journal of Woman and Child Health
Verified
Journal Article
Open access
KAKhanty-Mansiysk Khanty-Mansiysk State Medical Academy
Khanty-Mansiysk Khanty-Mansiysk State Medical Academy
AGA.A. Girina
A.A. Girina
FPF.I. Petrovski
F.I. Petrovski
AZA.L. Zaplatnikov
A.L. Zaplatnikov
MEMoscow Russian Medical Academy Of Continuous Professional Education
Moscow Russian Medical Academy Of Continuous Professional Education
In 2019, the World Health Organization (WHO) for the first time included refusal of vaccination in the list of ten global threats to humanity, since a decrease in vaccination coverage can trigger breakouts of many preventable infectious diseases. Aim: to clarify the causes for insufficient doctors’ adherence to immunoprophylaxis of infectious diseases and to develop measures for eliminating these causes. Patients and Methods: an open pilot online survey of 175 pediatricians working in medical institutions of the Khanty-Mansiysk Autonomous Okrug–Yugra (KMAO-Yugra) was conducted. The questionnaire contained 14 questions about the respondents’ attitude to various aspects of vaccinal prevention, as well as the level of respondent training on this topic. At the same time, a point scale was used to evaluate the provisions offered to the respondent for analysis (the minimum score is 0 points, the maximum score is 5 points). Results: 71–76% of respondents were convinced of the vaccination efficacy and safety. The main reasons for the lack of adherence to immunoprophylaxis of infectious diseases among the surveyed pediatricians were the insufficient level of knowledge due to the lack of continuous medical education on vaccinal prevention during the entire period of professional activity (25% of hospital-based physicians, 20% of doctors of educational institutions, 16% of health officials and 9% of general practitioners) and the use of information obtained from unofficial sources presented in the global Internet (25% of respondents). The study found that 13% of the physicians surveyed were not familiar with the recommendations for vaccination of pregnant women against influenza, and 24% were not informed about the possibilities, efficacy and safety of pregnant women vaccination against pertussis. Methods to increase the pediatricians’ adherence level to vaccination are outlined, the key among which is mandatory periodic professional development in immunoprophylaxis of infectious diseases in the system of continuing professional education. Conclusion: almost every fifth pediatrician of the KMAO-Yugra surveyed has an insufficient adherence level to immunoprophylaxis of infectious diseases. The article outlines the methods to increase the pediatricians’ adherence level to vaccination. KEYWORDS: vaccination, pediatrician, immunoprophylaxis, continuing professional education, vaccination coverage, continuing education, adherence to vaccination. FOR CITATION: Girina A.A., Petrovski F.I., Zaplatnikov A.L. Pediatricians adherence to immunoprophylaxis of infectious diseases: current state of the problem. Russian Journal of Woman and Child Health. 2020;3(4):290–294. DOI: 10.32364/2618-8430-2020-3-4-290-294.

28 March 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
NGNatalia Geppe
Natalia Geppe
AZAndrey L. Zaplatnikov
Andrey L. Zaplatnikov
EKElena Gennadievna Kondyurina
Elena Gennadievna Kondyurina
MCMaria M. Chepurnaya
Maria M. Chepurnaya
NKNatalia G. Kolosova
Natalia G. Kolosova
The common cold, which is mostly caused by respiratory viruses and clinically represented by the symptoms of acute respiratory viral infections (ARVI) with mainly upper respiratory tract involvement, is an important problem in pediatric practice. Due to the high prevalence, socio-economic burden, and lack of effective prevention measures (except for influenza and, partially, RSV infection), ARVI require strong medical attention. The purpose of this descriptive literature review was to analyze the current practical approaches to the treatment of ARVI to facilitate the choice of therapy in routine practice. This descriptive overview includes information on the causative agents of ARVI. Special attention is paid to the role of interferon gamma as a cytokine with antiviral and immunomodulatory effects on the pathogenesis of ARVI. Modern approaches to the treatment of ARVI, including antiviral, pathogenesis-directed and symptomatic therapy are presented. The emphasis is on the use of antibody-based drugs in the immunoprophylaxis and immunotherapy of ARVI. The data presented in this review allow us to conclude that a modern, balanced and evidence-based approach to the choice of ARVI treatment in children should be used in clinical practice. The published results of clinical trials and systematic reviews with meta-analyses of ARVI in children allow us to conclude that it is possible and expedient to use broad-spectrum antiviral drugs in complex therapy. This approach can provide an adequate response of the child’s immune system to the virus without limiting the clinical possibilities of using only symptomatic therapy.

1 January 2021 in Russian Journal of Woman and Child Health
Verified
Journal Article
Open access
AZA.L. Zaplatnikov
A.L. Zaplatnikov
MEMoscow Russian Medical Academy Of Continuous Professional Education
Moscow Russian Medical Academy Of Continuous Professional Education
AGA.A. Girina
A.A. Girina
VSV.I. Svintsitskaya
V.I. Svintsitskaya
ILI.V. Lepiseva
I.V. Lepiseva
PHPetrozavodsk Children’s Republican Hospital
Petrozavodsk Children’s Republican Hospital

1 January 2021 in Russian Journal of Woman and Child Health
Verified
Journal Article
Open access
AGA.A. Girina
A.A. Girina
KAKhanty-Mansiysk Khanty-Mansiysk State Medical Academy
Khanty-Mansiysk Khanty-Mansiysk State Medical Academy
AZA.L. Zaplatnikov
A.L. Zaplatnikov
FPF.I. Petrovskiy
F.I. Petrovskiy
LTL.P. Tandalova
L.P. Tandalova
KHKhanty-Mansiysk 3District Clinical Hospital
Khanty-Mansiysk 3District Clinical Hospital

1 January 2022 in Russian Medical Inquiry
Verified
Journal Article
Open access
VBV.A. Belov
V.A. Belov
EKE.P. Karpova
E.P. Karpova
AZA.L. Zaplatnikov
A.L. Zaplatnikov
AGA.A. Girina
A.A. Girina
ILI.V. Lepiseva
I.V. Lepiseva
PHPetrozavodsk Children’s Republican Hospital
Petrozavodsk Children’s Republican Hospital
Since January 1, 2022, the provision of medical care in most common infectious and inflammatory human diseases as acute respiratory infections (ARI) has already been carried out according to the relevant clinical recommendations (CRs) approved by the Ministry of Health of the Russian Federation. Due to the fact that ARI in the vast majority of cases are caused by viruses, much attention is paid to rational antibiotic therapy and the use of phytopreparations as a reasonable alternative to down the growth rate of antibiotic resistance. The article highlights the therapeutic possibilities of modern phytotherapy in the treatment of children with the most common manifestations of ARI (rhinosinusitis, tonsillopharyngitis, bronchitis) based on the CRs. A brief description of etiological factors, clinical symptoms, and diagnostic characteristics is given. The article also presents the results of in vitro and in vivo work, pathogenetically substantiating the expediency of using phytopreparations in ARI, as well as clinical research data confirming their efficacy and safety, including in children. It is particularly noted that following the CRs concerning patient management with ARI will reduce the frequency of unjustified prescribing of antibacterial drugs and polypragmasia in general, as well as improve the medical care quality. KEYWORDS: acute respiratory infections, rhinosinusitis, tonsillopharyngitis, bronchitis, clinical recommendations, phytotherapy, evidence- based medicine. FOR CITATION: Belov V.A., Karpova E.P., Zaplatnikov A.L. et al. Acute respiratory infections: current clinical recommendations. Focus on the issues of phytotherapy. Russian Medical Inquiry. 2022;6(7):376–386 (in Russ.). DOI: 10.32364/2587-6821-2022-6-7-376-386.